Impact of denosumab on bone mass in cancer patients

Ursa Brown-Glaberman, Alison T StopeckUniversity of Arizona Cancer Center, Tucson, AZ, USAAbstract: Cancer therapy-induced bone loss (CTIBL) is a form of secondary osteoporosis associated with systemic chemotherapy and hormonal ablation therapy. The monitoring and treatment of CTIBL is an important...

Full description

Saved in:
Bibliographic Details
Main Authors: Brown-Glaberman U, Stopeck AT
Format: article
Language:EN
Published: Dove Medical Press 2013
Subjects:
Online Access:https://doaj.org/article/78823999925b406a81c169e57d1323fd
Tags: Add Tag
No Tags, Be the first to tag this record!